|
¸®Æ÷Æ® ½ºÅ©¸° (1/2 screen)
¡Ø ÃÖ´ë 10ÆäÀÌÁö±îÁö ¸®Æ÷Æ® ½ºÅ©¸° À̹ÌÁö¸¦ »ý¼ºÇÕ´Ï´Ù.
¡Ø 5ÆäÀÌÁö ÀÌ»óÀÇ ÀÚ·áÀÎ °æ¿ì À̹ÌÁö¸¦ Ŭ¸¯ÇϽøé 2,4 ÆäÀÌÁö¿¡ ÇØ´çÇÏ´Â Å« À̹ÌÁö¸¦ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù
| ¼Ò°³±Û |
Vasculitis ÀÇ Á¤ÀÇ, ºÐ·ù¿Í ÀÓ»ó¼Ò°ß¿¡ °üÇÑ ÀÇÇз¹Æ÷Æ®ÀÔ´Ï´Ù.
Ã¥, ³í¹®, ÀÇÇÐÀú³ÎÀ» Âü°íÇÏ¿© Á÷Á¢ ŸÀÌÇÎÇÑ ÀÚ·áÀÔ´Ï´Ù. |
|
| ¸ñÂ÷ |
1. Á¤ÀÇ
2. ºÐ·ù
3. Ç÷°ü¼Õ»óÀÇ ±âÀü
4. primary vasculitis syndrome
5. secondary vasculitis
6. Reference
º» ÀÚ·á´Â ¿öµð¾ÈÀ̳ª ÇÑ±Û 2002 ÀÌ»óÀÇ ¹öÀü¿¡¼¸¸ È®ÀÎÀÌ °¡´ÉÇÕ´Ï´Ù.
ÇÑ±Û 97 ÀÌÇÏÀÇ ¹öÀüÀ» º¸À¯ÇÏ°í °è½Å ȸ¿ø´Ôµé²²¼´Â ±¸¸Å¿¡ ¾Õ¼ Âü°íÇϽñ⠹ٶø´Ï´Ù.
<ÇØÇÇÄ·ÆÛ½º ÀÚ·á°ü¸®ÆÀ> |
|
| º»¹®³»¿ë |
3. Ç÷°ü¼Õ»óÀÇ ±âÀü
1) º´¿ø¼º ¸é¿ªº¹ÇÕü Çü¼º(pathogenic immune complex formation)
¸é¿ªº¹ÇÕü ¸Å°³¼º Ç÷°ü¿°¿¡¼ Á¶Á÷¼Õ»óÀÇ ±âÀüÀº Ç׿ø-Ç×ü º¹ÇÕü°¡ Ç׿ø °ú´Ù»óÅ¿¡¼ Çü¼ºµÇ¾î Ç÷°üº®¿¡ Ä§ÂøµÇ°í, IgE À¯¹ß±âÀüÀÇ °á°ú·Î platelet ¶Ç´Â mast cell¿¡¼ ºÐºñµÇ´Â histamine, bradykinin, leukotrien°ú °°Àº vasoactive amines°¡ Áõ°¡µÇ¾î Ç÷°üº®ÀÇ Åõ°ú¼ºÀ» Áõ°¡½ÃŲ´Ù. ¸é¿ªº¹ÇÕüÀÇ Ä§ÂøÀº neutrophilÀÇ °·ÂÇÑ chemotactic factorÀÎ C5a¿Í °°Àº º¸Ã¼¸¦ Ȱ¼ºÈ½ÃŲ´Ù. neutrophilÀº Ç÷°üº®¿¡ ħÀ±ÇÏ¿© ¸é¿ªº¹ÇÕü¸¦ ޽ÄÇÏ°í ¼¼Æ÷Áú ³»ÀÇ È¿¼Ò¸¦ ¹æÃâ½ÃÄÑ Ç÷°üº®ÀÇ ¼Õ»óÀ» ÃÊ·¡ÇÑ´Ù.
2) Ç×Áß¼º±¸ ¼¼Æ÷Áú Ç×ü(antineutrophil cytoplasmic antibodies, ANCA)
ANCA´Â neutrophil°ú monocyteÀÇ ¼¼Æ÷Áú °ú¸³¿¡ Á¸ÀçÇϴ ƯÁ¤ ´Ü¹éÁú¿¡ ´ëÇÑ Ç×üÀÌ´Ù.
ANCA´Â Ç¥ÀûÇ׿ø¿¡ µû¶ó c-ANCA¿Í p-ANCA·Î ºÐ·ùµÈ´Ù. neutrophilÀÇ azurophilic granule ³»¿¡ Á¸ÀçÇÏ´Â proteinase-3°¡ °¡Àå Áß¿äÇÑ c-ANCAÀÇ Ç׿øÀÌ´Ù. p-ANCAÀÇ ÁÖ Ç¥ÀûÈ¿¼Ò´Â myeloperoxidaseÀÌ´Ù.
Proteinase-3¿Í myeloperoxidase´Â azurophilic granule°ú ÈÞÁö±âÀÇ neutrophil¿Í monocyteÀÇ lysosome¿¡ ÀÖÀ¸¸ç, À̵鿡°Ô ºÐ¸íÈ÷ Ç÷û Ç×üµéÀÌ Á¢±ÙÇÒ ¼ö ¾ø´Ù. ±×·¯³ª neutrophil°ú monocyte°¡ TNF-¥á ¶Ç´Â IL-1¿¡ ÀÇÇØ Ȱ¼ºÈµÇ¸é proteinase-3°ú myeloperoxidase´Â ¼¼Æ÷¸·À¸·Î ÀüÀ§µÇ¾î ¼¼Æ÷¿ÜÀÇ ANCA¿Í ¹ÝÀÀÇÏ°Ô µÈ´Ù. ÀÌ·Î ÀÎÇØ neutrophilÀº Å»°ú¸³ÈµÇ¸é¼ ¹ÝÀÀ¼º »êȹ°ÁúÀ» »ý»êÇÏ¿© Á¶Á÷¼Õ»óÀ» ÀÏÀ¸Å²´Ù.
3) º´Àû T¸²ÇÁ±¸ ¹ÝÀÀ°ú À°¾ÆÁ¾ Çü¼º(Pathogenic T Lymphocyte Responses and Granuloma Formation)
Ç÷°ü³»ÇǼ¼Æ÷´Â IFN-¥ã¿Í °°Àº cytokineÀÇ È°¼ºÈ·Î Á¦2Çü Á¶Á÷ÀûÇÕ¼º Ç׿ø(HLA class¥±)À» ¹ßÇöÇÒ ¼ö ÀÖ´Ù. ÀÌµé ¼¼Æ÷µéÀº antigen presenting cell·Î¼ CD4+T¸²ÇÁ±¸¿Í »óÈ£ÀÛ¿ëÀ» ÇÏ´Â ¸é¿ª¹ÝÀÀÀÌ ÀϾµµ·Ï ÇÑ´Ù. ³»ÇǼ¼Æ÷´Â IL-1À» ºÐºñÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â T¸²ÇÁ±¸¸¦ Ȱ¼ºÈ½Ã۰í Ç÷°üº®¿¡¼ ¸é¿ª °úÁ¤À» ÀÏÀ¸Å²´Ù.
|
|
| Âü°íÀÚ·á |
- Kasper, Braunwald, Fauci, Hauser, Lango, Jameson. 16th edition, 2006; 2185-2198.
- J.T.Scott. 6th edition; 1284-1289; 1292-1314.
- Carlo Salvarani, M.D., Fabrizio Cantini, M.D., Luigi Boiardi, M.D., Ph.D., and Gene G. Hunder, M.D. Polymyalgia Rheumatica and Giant-Cell Arteritis. N Engl J Med 2002; vol347:261-271.
- Cornelia M. Weyand, M.D., Ph.D., and Jörg J. Goronzy, M.D., Ph.D. Medium- and Large-Vessel Vasculitis. N Engl J Med 2003; vol349:160-169 |
|
| Çб³Á¤º¸ |
2ÁÖ°£ ´Ù¿î¹ÞÀº ÇлýÀÇ Çб³Á¤º¸¸¦ º¸¿©ÁÝ´Ï´Ù.(5P ¼Ò¿ä)
 |
|
 |
| ÀúÀÛ±Ç Á¤º¸ |
À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ Áø½Ç¼º¿¡ ´ëÇÏ¿© ÇØÇÇÄ·ÆÛ½º´Â º¸ÁõÇÏÁö ¾Æ´ÏÇϸç, ÇØ´ç Á¤º¸ ¹× °Ô½Ã¹° ÀúÀ۱ǰú ±âŸ ¹ýÀû Ã¥ÀÓÀº ÀÚ·á µî·ÏÀÚ¿¡°Ô ÀÖ½À´Ï´Ù. À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ ºÒ¹ýÀû ÀÌ¿ë, ¹«´Ü ÀüÀ硤¹èÆ÷´Â ±ÝÁöµÇ¾î ÀÖ½À´Ï´Ù.ÀúÀÛ±ÇÄ§ÇØ, ¸í¿¹ÈÑ¼Õ µî ºÐÀï¿ä¼Ò ¹ß°ß½Ã °í°´¼¾ÅÍÀÇ ÀúÀÛ±ÇÄ§ÇØ ½Å°í¼¾Å͸¦ ÀÌ¿ëÇØ Áֽñ⠹ٶø´Ï´Ù. |
 |
|
|